Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD) on Positive Interim Data from GS7977 Trials
Go back to Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD) on Positive Interim Data from GS7977 Trials| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.83 -0.82 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.65 | 52 Week High | $77.12 | |||
| Open | $64.13 | 52 Week Low | $49.03 | |||
| Day High | $64.33 | P/E | 41.45 | |||
| Day Low | $63.35 | EPS | $1.54 | |||
| Volume | 7,529,798 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.36 +0.22 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.14 | 52 Week High | $108.63 | |||
| Open | $136.81 | 52 Week Low | $71.39 | |||
| Day High | $138.43 | P/E | 76.44 | |||
| Day Low | $135.91 | EPS | $1.81 | |||
| Volume | 3,407,717 | |||||
